Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 97

1.
2.

MTRR A66G polymorphism and breast cancer risk: a meta-analysis.

Hu J, Zhou GW, Wang N, Wang YJ.

Breast Cancer Res Treat. 2010 Dec;124(3):779-84. doi: 10.1007/s10549-010-0892-1. Epub 2010 Apr 22.

PMID:
20411324
3.

Methionine synthase reductase A66G polymorphism and leukemia risk: evidence from published studies.

Fang DH, Ji Q, Fan CH, An Q, Li J.

Leuk Lymphoma. 2014 Aug;55(8):1910-4. doi: 10.3109/10428194.2013.867492. Epub 2014 Jan 24.

PMID:
24261678
4.

A meta-analysis of MTRR A66G polymorphism and colorectal cancer susceptibility.

Wu PP, Tang RN, An L.

J BUON. 2015 May-Jun;20(3):918-22. Review.

PMID:
26214647
5.

Methionine synthase reductase A66G polymorphism contributes to tumor susceptibility: evidence from 35 case-control studies.

Han D, Shen C, Meng X, Bai J, Chen F, Yu Y, Jin Y, Fu S.

Mol Biol Rep. 2012 Feb;39(2):805-16. doi: 10.1007/s11033-011-0802-6. Epub 2011 May 6.

PMID:
21547363
6.

[Association of methionine synthase reductase gene polymorphism with unexplained recurrent spontaneous abortion].

Guo QN, Liao SX, Kang B, Zhang JX, Wang RL, Ding XB, Zhang WH.

Zhonghua Fu Chan Ke Za Zhi. 2012 Oct;47(10):742-6. Chinese.

PMID:
23302731
7.

Association between MTR A2756G and MTRR A66G polymorphisms and maternal risk for neural tube defects: a meta-analysis.

Ouyang S, Li Y, Liu Z, Chang H, Wu J.

Gene. 2013 Feb 25;515(2):308-12. doi: 10.1016/j.gene.2012.11.070. Epub 2012 Dec 22.

PMID:
23266814
8.

Genetic variant in MTRR, but not MTR, is associated with risk of congenital heart disease: an integrated meta-analysis.

Cai B, Zhang T, Zhong R, Zou L, Zhu B, Chen W, Shen N, Ke J, Lou J, Wang Z, Sun Y, Liu L, Song R.

PLoS One. 2014 Mar 4;9(3):e89609. doi: 10.1371/journal.pone.0089609. eCollection 2014.

9.

Meta-analyses on the association of MTR A2756G and MTRR A66G polymorphisms with neural tube defect risks in Caucasian children.

Ouyang S, Liu Z, Li Y, Wu J.

J Matern Fetal Neonatal Med. 2013 Aug;26(12):1166-70. doi: 10.3109/14767058.2013.777699. Epub 2013 Mar 21.

PMID:
23425389
10.

Three genetic polymorphisms of homocysteine-metabolizing enzymes and risk of coronary heart disease: a meta-analysis based on 23 case-control studies.

Chen L, Liu L, Hong K, Hu J, Cheng X.

DNA Cell Biol. 2012 Feb;31(2):238-49. doi: 10.1089/dna.2011.1281. Epub 2011 Jul 22.

PMID:
21780915
11.

Association between methionine synthase reductase A66G polymorphism and primary infertility in Chinese males.

Li XY, Ye JZ, Ding XP, Zhang XH, Ma TJ, Zhong R, Ren HY.

Genet Mol Res. 2015 Apr 15;14(2):3491-500. doi: 10.4238/2015.April.15.13.

12.

Are MTHFR C677T and MTRR A66G Polymorphisms Associated with Overweight/Obesity Risk? From a Case-Control to a Meta-Analysis of 30,327 Subjects.

Fan SJ, Yang BY, Zhi XY, He M, Wang D, Wang YX, Wang YN, Wei J, Zheng QM, Sun GF.

Int J Mol Sci. 2015 May 26;16(6):11849-63. doi: 10.3390/ijms160611849.

13.

Associations of MTHFR C677T and MTRR A66G gene polymorphisms with metabolic syndrome: a case-control study in Northern China.

Yang B, Fan S, Zhi X, Wang D, Li Y, Wang Y, Wang Y, Wei J, Zheng Q, Sun G.

Int J Mol Sci. 2014 Nov 25;15(12):21687-702. doi: 10.3390/ijms151221687.

14.

Association between Methionine Synthase Reductase A66G Polymorphism and Male Infertility: A Meta-Analysis.

Xu W, Zhang L, Wu X, Jin F.

Crit Rev Eukaryot Gene Expr. 2017;27(1):37-46. doi: 10.1615/CritRevEukaryotGeneExpr.2017018680.

PMID:
28436330
15.

One-carbon metabolism-related gene polymorphisms and risk of breast cancer.

Suzuki T, Matsuo K, Hirose K, Hiraki A, Kawase T, Watanabe M, Yamashita T, Iwata H, Tajima K.

Carcinogenesis. 2008 Feb;29(2):356-62. doi: 10.1093/carcin/bgm295. Epub 2008 Jan 3.

PMID:
18174236
16.

Association between methionine synthase reductase A66G polymorphism and the risk of congenital heart defects: evidence from eight case-control studies.

Yu D, Yang L, Shen S, Fan C, Zhang W, Mo X.

Pediatr Cardiol. 2014 Oct;35(7):1091-8. doi: 10.1007/s00246-014-0948-9. Epub 2014 Jun 10. Review.

PMID:
24913415
17.

Association of MTRR A66G polymorphism with cancer susceptibility: Evidence from 85 studies.

Wang P, Li S, Wang M, He J, Xi S.

J Cancer. 2017 Jan 15;8(2):266-277. doi: 10.7150/jca.17379. eCollection 2017.

18.
19.

A66G and C524T polymorphisms of methionine synthase reductase gene are linked to the development of acyanotic congenital heart diseases in Egyptian children.

Hassan FM, Khattab AA, Abo El Fotoh WMM, Zidan RS.

Gene. 2017 Sep 20;629:59-63. doi: 10.1016/j.gene.2017.07.081. Epub 2017 Aug 2.

PMID:
28778621
20.

A66G and C524T polymorphisms of the methionine synthase reductase gene are associated with congenital heart defects in the Chinese Han population.

Zeng W, Liu L, Tong Y, Liu HM, Dai L, Mao M.

Genet Mol Res. 2011 Oct 25;10(4):2597-605. doi: 10.4238/2011.October.25.7.

Supplemental Content

Support Center